Lanthanum Carbonate (Fosrenol ®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
Conditions: Secondary Hyperoxaluria; Nephrolithiasis Intervention: Drug: Lanthanum Carbonate Sponsor: Universitair Ziekenhuis Brussel Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Kidney Stones | Research